A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy

Frank A Vicini,G Bruce Mann,Chirag Shah,Sheila Weinmann,Michael C Leo,Pat Whitworth,Rachel Rabinovitch,Mylin A Torres,Julie A Margenthaler,David Dabbs,Jess Savala,Steven C Shivers,Karuna Mittal,Fredrik Wärnberg,Troy Bremer

International Journal of Radiation Oncology*Biology*Physics（2023）

引用 8|浏览45

暂无评分

摘要

The novel biosignature identified patients with 3 distinct risk profiles: Low Risk patients with a low recurrence risk with or without adjuvant RT, Elevated Risk patients with excellent outcomes after BCS plus RT, and Residual Risk patients with an elevated recurrence risk remaining after BCS plus RT, warranting potential intensified or alternative treatment approaches.

查看译文

关键词

dcis,radiation therapy,novel biosignature identifies patients,breast,surgery

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要